Cancer Treatment Reviews
Volume 31, Issue 4 , Pages 332-335, June 2005

Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia:☆☆☆☆☆☆

Abstracted from: Zhu Q, Tan DCL, Samuel M, Chan ESY, Linn YC. Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukaemia: A systematic review and meta-analysis. Leukaemia Lymphoma 2004; 45:2239–45.

CTSU, Radcliffe Infirmary, Oxford University, Harkness Building, Oxford OX2 6HE, UK

published online 16 May 2005.

(Sue Richards is a co-reviewer of Purine antagonists for the treatment of chronic lymphocytic leukaemia, a Cochrane review in progress.)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Sources of funding: Not stated.

☆☆ For c.orrespondence: Linn YC, Department of Hematology, Singapore General Hospital, Blk 6, Level 3, Outram Road, Singapore 169608, Singapore. E-mail: ghelyc@sgh.com.sg

☆☆☆ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(05)00073-3

doi:10.1016/j.ctrv.2005.04.002

Cancer Treatment Reviews
Volume 31, Issue 4 , Pages 332-335, June 2005

Article Tools